European Journal of Vascular and Endovascular Surgery最新文献

Objective: Data validity and completeness is essential for registry data, and a meaningful interpretation of differences between countries can only be made if the data are robust within each of the countries. Therefore, the VASCUNET collaboration has performed validation of several vascular registries and has so far published the validation results of national vascular registries of Sweden, Denmark, and Malta. The findings of the validation of the Swissvasc Registry, the vascular registry of Switzerland, are presented here.

Methods: Five of 34 hospitals participating in Swissvasc were visited by two international validators. Independent evaluation of the procedures of carotid endarterectomy, infrarenal abdominal aortic aneurysm (AAA) repair, and bypass surgery for lower extremity arterial disease (LEAD) was performed. Local administrative data and Swissvasc Registry data were compared for external validation, as well as registry data of 15 randomly picked cases within each group with data from individual patient records for internal validation.

Results: Hospital administrative data identified 265 carotid, 399 AAA, and 399 LEAD procedures, whereas Swissvasc identified 265 carotid, 398 AAA, and 395 LEAD procedures. Four LEAD procedures were found in hospital administrative data but not in Swissvasc. External validity was 100% for carotids, 99.8% for AAA, and 99% for LEAD. In internal validation, 5.2% of the variable data were missing in Swissvasc, and 2.4% were different from data in patient records, resulting in external validity of 92.8% for carotids, 94.4% for AAA, and 90.1% for LEAD.

Conclusion: The VASCUNET template was used for international validation of registry data, and demonstrated that Swissvasc is a reliable system of quality data collection for the participating vascular centres, with excellent external validity and good internal validity. Quality in the Swissvasc registry data was clearly superior to local administrative data.

Objective: Patients with polyvascular disease are considered high risk for major adverse cardiac events (MACEs). This retrospective study utilised the Vascular Quality Initiative (VQI) database to quantify the effect of polyvascular disease on outcomes after endovascular aneurysm repair (EVAR).

Methods: The VQI database was queried from to 2012 - 2022 for elective EVAR. Patients were identified as having peripheral arterial disease, coronary artery disease, or cerebrovascular disease, and then stratified based on the number of arterial beds involved (one to three). Primary outcomes were peri-operative death and MACEs. Multivariate analysis was performed to find associations between comorbidities and primary outcomes.

Results: Of the 21 160 patients with arterial disease included in the study, 83.7% were male and the mean age was 73.73 ± 8.57 years. After stratification, 16 892 patients had atherosclerosis in one arterial bed, 3 869 in two arterial beds, and 399 in three arterial beds. Pre-operatively, patients with atherosclerosis in three arterial beds were more likely to have hypertension, diabetes, and renal failure (all p < .001). Post-operatively, patients with disease in three arterial beds were more likely to experience a post-operative complication (11.5% vs. 8.3% vs. 5.4%; p < .001), including MACE (4.6% vs. 4.1% vs. 2.8%; p < .001) and death (3.0% vs. 2.5% vs. 1.7%; p < .010). On multivariate analysis, polyvascular disease was associated with MACEs (odds ratio 1.54, 95% confidence interval 1.29 - 1.84; p < .001). Kaplan-Meier analysis estimates showed statistically significant differences in survival at approximately the three year follow up (p < .001).

Conclusion: In this review of patients undergoing elective EVAR, patients with polyvascular disease experienced worse peri-operative outcomes, including death and MACEs, the latter of which was confirmed on multivariable analysis. These patients should be considered high risk and managed accordingly.